{"root":[{"id":15531538,"innercode":"734806000001000000","name":"一 我国保健食品原料的分类及使用情况","children":[{"id":15532514,"innercode":"734806000001000000000000","name":"（一）我国保健食品原料分类"},{"id":15532528,"innercode":"734806000001000000000001","name":"（二）我国保健食品原料的使用情况"}]},{"id":15531546,"innercode":"734806000001000001","name":"二 我国保健食品原料管理的历史沿革及现状"},{"id":15531551,"innercode":"734806000001000002","name":"三 我国保健食品原料管理存在的问题","children":[{"id":15532536,"innercode":"734806000001000002000000","name":"（一）保健食品原料界定及监管待优化"},{"id":15532541,"innercode":"734806000001000002000001","name":"（二）保健食品原料目录制定进程缓慢且评价体系待完善"},{"id":15532547,"innercode":"734806000001000002000002","name":"（三）中药原料功能声称缺乏科学评价"},{"id":15532554,"innercode":"734806000001000002000003","name":"（四）缺乏专业权威的技术支撑机构"}]},{"id":15531557,"innercode":"734806000001000003","name":"四 我国保健食品原料管理的建议","children":[{"id":15532559,"innercode":"734806000001000003000000","name":"（一）加快原料目录研究工作，明确原料源头信息、安全范围和功能定位"},{"id":15532563,"innercode":"734806000001000003000001","name":"（二）建立原料风险分级分类管理制度"},{"id":15532572,"innercode":"734806000001000003000002","name":"（三）统筹保健食品原料管理与声称管理"},{"id":15532580,"innercode":"734806000001000003000003","name":"（四）压实企业主体责任"},{"id":15532587,"innercode":"734806000001000003000004","name":"（五）建立专业的技术支撑机构和合理的保健食品原料再评价体系"}]}]}